You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stomach Cancer, Adenocarcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stomach Cancer, Adenocarcinoma Trial in Seoul (Durvalumab, Savolitinib)

Recruiting
  • Stomach Cancer, Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 10, 2023

Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)

Recruiting
  • Gastric Cancer
  • +10 more
  • Kyiv, Ukraine
    National Cancer Institute
Aug 31, 2023

Gastric Cancer Trial in Beijing (Apatinib, Oxaliplatin, S1)

Recruiting
  • Gastric Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023

Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

Recruiting
  • Adenocarcinoma
  • +8 more
  • Radiotherapy targeted to the primary lesion
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 7, 2023

Stomach Tumors Trial in Shanghai (Fruquintinib, Sintilimab)

Active, not recruiting
  • Stomach Neoplasms
  • Shanghai, China
    Renji Hospital
Apr 3, 2023

Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Chuo Ku (TRK-950, Ramucirumab,

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • TRK-950
  • +2 more
  • Chuo Ku, Japan
    Osaka International Cancer Institute
Sep 14, 2023

Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (XELOX combined with Fruquintinib and Sintilimab)

Not yet recruiting
  • Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
  • XELOX combined with Fruquintinib and Sintilimab
  • (no location specified)
Oct 17, 2023

Gastric Cancer Trial (S-1, Oxaliplatin, Cadonilimab)

Not yet recruiting
  • Gastric Cancer
  • S-1, Oxaliplatin, Cadonilimab
  • (no location specified)
Jul 10, 2023

Gastric Cancer, Gastroesophageal-junction Cancer Trial (IBI315, Oxaliplatin, Capecitabine)

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal-junction Cancer
  • (no location specified)
Nov 2, 2022

Gastric Cancer, GastroEsophageal Cancer, Fruquintinib Trial in Nanning (Fruquintinib + SOX)

Recruiting
  • Gastric Cancer
  • +3 more
  • Fruquintinib + SOX
  • Nanning, China
    Guangxi Medical University Cancer Hospital
Dec 2, 2022

HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811, Ramucirumab / Paclitaxel/

Not yet recruiting
  • HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
  • SHR-A1811
  • Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan
  • (no location specified)
Nov 6, 2023

Gastric Adenocarcinoma, Esophagogastric Junction, Gastric Cancer Trial run by the National Cancer Institute (NCI) (Surgery,

Recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Surgery
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Gastric Cancer Trial

Completed
  • Gastric Cancer
    • (no location specified)
    Dec 20, 2022

    HER2+ Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811;SHR-1701;capecitabine;oxaliplatin)

    Not yet recruiting
    • HER2+ Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
    • (no location specified)
    Jan 3, 2023

    Gastric Cancer Trial (Fruquintinib)

    Not yet recruiting
    • Gastric Cancer
    • (no location specified)
    Oct 17, 2023

    A Recurrence Nomogram for Hepatoid Adenocarcinoma of the Stomach

    Completed
    • Gastric Cancer
      • Fuzhou, Fujian, China
        Fujian Medical University Union Hospital
      Mar 9, 2022

      Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Capecitabine, oxaliplatin, Disitamab Vedotin)

      Not yet recruiting
      • Gastric Cancer
      • Gastroesophageal Junction Adenocarcinoma
      • Beijing, Beijing, China
      • +10 more
      Nov 23, 2023

      Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Japan (ASP2138)

      Recruiting
      • Gastric Adenocarcinoma
      • +2 more
      • Santa Monica, California
      • +5 more
      Dec 13, 2022

      Stomach Tumors, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Atezolizumab, Tiragolumab, Oxaliplatin)

      Active, not recruiting
      • Stomach Neoplasms
      • +2 more
      • Beijing, China
      • +10 more
      Dec 21, 2022

      Esophagus Cancer, Adenocarcinoma, Stomach Cancer, Adenocarcinoma Trial in United States (Rucaparib, Ramucirumab, Nivolumab)

      Recruiting
      • Esophagus Cancer, Adenocarcinoma
      • Stomach Cancer, Adenocarcinoma
      • Chicago, Illinois
      • +7 more
      Jan 31, 2022

      Stomach Tumor Trial in Chengdu (Capeox regimen combined with Sintilimab and Bevacizumab)

      Not yet recruiting
      • Stomach Neoplasm
      • Capeox regimen combined with Sintilimab and Bevacizumab
      • Chengdu, China
        Liu Ming
      Nov 28, 2022

      HER2-positive Locally Advanced Resectable Gastric Cancer Trial (KN026, KN046, XELOX)

      Not yet recruiting
      • HER2-positive Locally Advanced Resectable Gastric Cancer
      • (no location specified)
      Sep 3, 2023

      HER2-positive Advanced Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma Trial (Trastuzumab deruxtecan)

      Not yet recruiting
      • HER2-positive Advanced Gastric Cancer
      • HER2-positive Gastroesophageal Junction Adenocarcinoma
      • Trastuzumab deruxtecan
      • (no location specified)
      Aug 11, 2023

      Cancer of Stomach, Oesophageal Cancer, Gastric Cancer Trial in Sydney

      Recruiting
      • Cancer of Stomach
      • +8 more
        • Sydney, New South Wales, Australia
          Westmead Hospital
        Mar 26, 2023

        Advanced Gastric Cancer Trial in Shanghai (Transcatheter Arterial Chemoembolization, Tislelizumab)

        Recruiting
        • Advanced Gastric Cancer
        • Shanghai, Shanghai, China
          ZhongShan hospital Fudan university
        May 25, 2022